TABLE 2.
Variables | Univariate |
Multivariate |
||||||
P-value | HR | HR.95L | HR.95H | P-value | HR | HR.95L | HR.95H | |
Age (> 50/ < 50) | < 0.001 | 2.229 | 1.398 | 3.554 | 0.01 | 1.856 | 1.158 | 2.974 |
Gender (female/male) | 0.79 | 1.043 | 0.764 | 1.425 | − | |||
Clinical stage (III–IV/I–II) | < 0.001 | 3.734 | 2.716 | 5.134 | 0.002 | 2.871 | 1.465 | 5.624 |
M (M1–MX/M0) | < | 3.701 | 2.712 | 5.05 | 0.001 | 1.804 | 1.263 | 2.575 |
N (N1–NX/N0) | 0.507 | 0.903 | 0.669 | 1.22 | − | |||
T (T3–T4/T1–T2) | <0.001 | 3.042 | 2.242 | 4.127 | 0.419 | 0.78 | 0.426 | 1.427 |
Grade (G3–G4/G1–G2) | <0.001 | 2.643 | 1.875 | 3.726 | 0.011 | 1.611 | 1.116 | 2.326 |
Risk score | <0.001 | 2.553 | 1.977 | 3.296 | < 0.001 | 2.07 | 1.537 | 2.789 |